| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ... Nature genetics 45 (12), 1452-1458, 2013 | 2893 | 2013 |
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ... Nature genetics 41 (10), 1088-1093, 2009 | 2684 | 2009 |
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ... Nature genetics 43 (5), 429-435, 2011 | 1656 | 2011 |
| CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ... Jama 302 (4), 385-393, 2009 | 1217 | 2009 |
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 893 | 2015 |
| Rivastigmine for Alzheimer's disease JS Birks, JG Evans Cochrane Database of systematic reviews, 2015 | 830 | 2015 |
| Analysis of shared heritability in common disorders of the brain V Anttila, B Bulik-Sullivan, HK Finucane, RK Walters, J Bras, L Duncan, ... Science 360 (6395), 2018 | 668 | 2018 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 653 | 2019 |
| Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA … PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ... The Lancet Neurology 8 (7), 619-627, 2009 | 599 | 2009 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 479 | 2017 |
| Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial M Emre, M Tsolaki, U Bonuccelli, A Destée, E Tolosa, A Kutzelnigg, ... The Lancet Neurology 9 (10), 969-977, 2010 | 413 | 2010 |
| Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease M Thambisetty, A Simmons, L Velayudhan, A Hye, J Campbell, Y Zhang, ... Archives of general psychiatry 67 (7), 739-748, 2010 | 411 | 2010 |
| Neuropsychiatric syndromes in dementia P Aalten, FRJ Verhey, M Boziki, R Bullock, EJ Byrne, V Camus, M Caputo, ... Dementia and geriatric cognitive disorders 24 (6), 457-463, 2007 | 374 | 2007 |
| Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ... Alzheimer's research & therapy 7 (1), 1-20, 2015 | 352 | 2015 |
| Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study E Castro-Costa, M Dewey, R Stewart, S Banerjee, F Huppert, ... The British journal of psychiatry 191 (5), 393-401, 2007 | 304 | 2007 |
| The validation of the short form of the Geriatric Depression Scale (GDS) in Greece KN Fountoulakis, M Tsolaki, A Iacovides, J Yesavage, R O’hara, A Kazis, ... Aging Clinical and Experimental Research 11 (6), 367-372, 1999 | 297 | 1999 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium Science (New York, NY) 360 (6395), 2018 | 266 | 2018 |
| Increased brain β-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism A Papassotiropoulos, JR Streffer, M Tsolaki, S Schmid, D Thal, F Nicosia, ... Archives of neurology 60 (1), 29-35, 2003 | 247 | 2003 |
| Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ... Brain 138 (5), 1327-1338, 2015 | 241 | 2015 |
| The cerebrospinal fluid “Alzheimer profile”: easily said, but what does it mean? FH Duits, CE Teunissen, FH Bouwman, PJ Visser, N Mattsson, ... Alzheimer's & Dementia 10 (6), 713-723. e2, 2014 | 240 | 2014 |
